The combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment…
MARIPOSA
Inaugurated by Andrés Cervantes (Valencia, Spain), President of the European Society for Medical Oncology (ESMO) and ESMO Congress 2023, this…
